Lissethe Palomo-Ligas

Dr. Lissethe Palomo-Ligas

Universidad Autonoma de Coahuila, Saltillo, Coahuila de Zaragoza, Mexico
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2024 in Fermentation
Verified
Journal Article
Open access
PDF file
YGYulma Lizbeth Aguirre Garcia
Yulma Lizbeth Aguirre Garcia
Sendar Daniel Nery-FloresSendar Daniel Nery-Flores
Sendar Daniel Nery-Flores
LCLizeth Guadalupe Campos-Muzquiz
Lizeth Guadalupe Campos-Muzquiz
Adriana Carolina Flores-GallegosAdriana Carolina Flores-Gallegos
Adriana Carolina Flores-Gallegos
Lissethe Palomo-LigasLissethe Palomo-Ligas
Lissethe Palomo-Ligas
RRRaul Rodriguez
Raul Rodriguez
Studies on fermentation by acid lactic bacteria (LAB) have confirmed the presence of strains with attributes of considerable relevance for food processing. These strains, in addition to their ability to modify the texture and flavor of foods, possess beneficial properties for human health. They enhance food quality by making it more nutrient-rich and contribute to food preservation. The production of lactic acid, vitamins, exopolysaccharides, and bacteriocins, among other compounds, confers these properties to LAB. In the realm of preservation, bacteriocins play a crucial role. This is because bacteriocins act by inhibiting the growth and reproduction of unwanted microorganisms by interacting with the cell membrane, causing its rupture. This preservative effect has led LAB to have widespread use during food processing. This preservative effect has led to widespread use of LAB during food processing. This review highlights the importance of fermentation carried out by LAB in the food industry and in the bio-preservation of foods. These findings emphasize the relevance of continuing investigations and harness the properties of LAB in food production.

1 August 2017 in Acta Tropica
Verified
Journal Article
Open access
Filiberto Gutiérrez-GutiérrezFiliberto Gutiérrez-Gutiérrez
Filiberto Gutiérrez-Gutiérrez
Lissethe Palomo-LigasLissethe Palomo-Ligas
Lissethe Palomo-Ligas
JHJosé Manuel Hernández-Hernández
José Manuel Hernández-Hernández
APArmando Pérez-Rangel
Armando Pérez-Rangel
RARodrigo Aguayo-Ortiz
Rodrigo Aguayo-Ortiz
ACAraceli Castillo-Romero
Araceli Castillo-Romero
Giardia lamblia is a worldwide protozoan responsible for a significant number of intestinal infections. There are several drugs for the treatment of giardiasis, but they often cause side effects. Curcumin, a component of turmeric, has antigiardial activity; however, the molecular target and mechanism of antiproliferative activity are not clear. The effects of curcumin on cellular microtubules have been widely investigated. Since tubulin is the most abundant protein in the cytoskeleton of Giardia, to elucidate whether curcumin has activity against the microtubules of this parasite, we treated trophozoites with curcumin and the cells were analyzed by scanning electron microscopy and confocal microscopy. Curcumin inhibited Giardia proliferation and adhesion in a time-concentration-dependent mode. The higher inhibitory concentrations of curcumin (3 and 15μM) disrupted the cytoskeletal structures of trophozoites; the damage was evident on the ventral disk, flagella and in the caudal region, also the membrane was affected. The immunofluorescence images showed altered distribution of tubulin staining on ventral disk and flagella. Additionally, we found that curcumin caused a clear reduction of tubulin expression. By docking analysis and molecular dynamics we showed that curcumin has a high probability to bind at the interface of the tubulin dimer close to the vinblastine binding site. All the data presented indicate that curcumin may inhibit Giardia proliferation by perturbing microtubules.

27 February 2019 in PeerJ
Verified
Journal Article
Open access
PDF file
Lissethe Palomo-LigasLissethe Palomo-Ligas
Lissethe Palomo-Ligas
Filiberto Gutiérrez-GutiérrezFiliberto Gutiérrez-Gutiérrez
Filiberto Gutiérrez-Gutiérrez
VOVerónica Yadira Ochoa-Maganda
Verónica Yadira Ochoa-Maganda
RCRafael Cortés-Zárate
Rafael Cortés-Zárate
CPCesar Pedroza-Roldan
Cesar Pedroza-Roldan
ACAraceli Castillo-Romero
Araceli Castillo-Romero
Background: The protozoan Giardia lamblia is the causal agent of giardiasis, one of the main diarrheal infections worldwide. Drug resistance to common antigiardial agents and incidence of treatment failures have increased in recent years. Therefore, the search for new molecular targets for drugs against Giardia infection is essential. In protozoa, ionic channels have roles in their life cycle, growth, and stress response. Thus, they are promising targets for drug design. The strategy of ligand-protein docking has demonstrated a great potential in the discovery of new targets and structure-based drug design studies. Methods: In this work, we identify and characterize a new potassium channel, GiK, in the genome of Giardia lamblia. Characterization was performed in silico. Because its crystallographic structure remains unresolved, homology modeling was used to construct the three-dimensional model for the pore domain of GiK. The docking virtual screening approach was employed to determine whether GiK is a good target for potassium channel blockers. Results: The GiK sequence showed 24–50% identity and 50–90% positivity with 21 different types of potassium channels. The quality assessment and validation parameters indicated the reliability of the modeled structure of GiK. We identified 110 potassium channel blockers exhibiting high affinity toward GiK. A total of 39 of these drugs bind in three specific regions. Discussion: The GiK pore signature sequence is related to the small conductance calcium-activated potassium channels (SKCa). The predicted binding of 110 potassium blockers to GiK makes this protein an attractive target for biological testing to evaluate its role in the life cycle of Giardia lamblia and potential candidate for the design of novel antigiardial drugs.

1 January 2024 in Journal of Toxicology
Verified
Journal Article
Open access
YGYulma Lizbeth Aguirre Garcia
Yulma Lizbeth Aguirre Garcia
ACAinara Castillo-Manzanares
Ainara Castillo-Manzanares
Lissethe Palomo-LigasLissethe Palomo-Ligas
Lissethe Palomo-Ligas
JAJ. A. Ascacio-Valdes
J. A. Ascacio-Valdes
LCLizeth Guadalupe Campos-Muzquiz
Lizeth Guadalupe Campos-Muzquiz
Sendar Daniel Nery-FloresSendar Daniel Nery-Flores
Sendar Daniel Nery-Flores
Flourensia cernua DC, commonly known as hojasen or tarbush, is a medicinal plant used in arid regions due to its therapeutic properties, especially in the treatment of gastrointestinal disorders. This study aimed to assess the toxicity of a polyphenolic extract obtained from F. cernua. This research involved both in vitro (hemolytic and brine shrimp assay) and in vivo tests (acute oral toxicity) to determine the safety profile of this extract. The extract was obtained through a novel ultrasound‐microwave extraction and purified by ion‐exchange chromatography. Analysis of the polyphenolic extract revealed a rich composition of flavonoids and hydroxycinnamic acids, mainly apigenin glycosides. In toxicity tests, the polyphenols did not exhibit toxicity towards Artemia salina at a concentration of 1 mg/ml. Furthermore, incubation at 500 μg/ml for 4 hours showed a slight toxic effect on erythrocytes. In the acute oral toxicity test in mice, doses of 300 mg/kg and 2000 mg/kg did not result in animal mortality, indicating that the LD50 exceeds 2000 mg/kg. However, the higher dose induced signs of toxicity, including lethargy, drowsiness, piloerection, and a significant decrease in weight during the initial two days postadministration of the polyphenolic extract. In addition, histological analysis suggested potential kidney damage at the 2000 mg/kg dose. According to OECD guidelines, while the extract can be classified as category 5 (low acute toxicity) due to the absence of mortality at 2000 mg/kg, the observed signs of toxicity should be considered in the overall risk assessment. These findings highlight the potential of F. cernua in pharmaceutical and nutraceutical applications due to its high polyphenolic content. However, further investigations are necessary to explore the specific effects of the compounds present in the extract. In addition, continuous evaluation of its long‐term toxicity is essential to fully understand the extract’s safety profile and efficacy.


27 December 2023 in Plant Science Today
Verified
Journal Article
Open access
PDF file
ALAndrea Linares-Braham
Andrea Linares-Braham
Lissethe Palomo-LigasLissethe Palomo-Ligas
Lissethe Palomo-Ligas
Sendar Daniel Nery-FloresSendar Daniel Nery-Flores
Sendar Daniel Nery-Flores
Flourensia cernua, commonly known as hojasen, is a shrub that is widely distributed in northern Mexico and the southern United States. The presence of this shrub indicates the characteristic flora of the Chihuahuan desert and southern Arizona, and it is an endemic plant of the Coahuila region in Mexico. The leaves and flowers of F. cernua are commercially available in Mexican markets for preparing infusions and are used as traditional medicine, mainly for gastrointestinal disorders such as indigestion, diarrhea, stomach pain, and dysentery, among others. Several studies have shown that F. cernua extracts contain bioactive compounds that can act as antioxidants in vitro by stopping free radicals from doing damage. In addition, F. cernua extracts have antifungal activity against phytopathogenic fungi. Additionally, F. cernua extracts have demonstrated antibacterial effects against Mycobacterium tuberculosis. Also, the anti-inflammatory effect of leaf extract at different doses has been studied to see how it affects the production of inflammatory cytokines and nitric oxide (NO) in macrophage cultures. Therefore, identifying its components and pharmacological properties can promote its use as an adjunct or therapeutic candidate in controlling various diseases. With its potential to alleviate gastrointestinal issues, provide antioxidant protection, and inhibit fungi and bacteria, hojasen extract may prove to be a valuable addition to the treatment of many diseases. This minireview aims to expand the existing knowledge about hojasen, a semi-desert shrub that possesses different bioactive compounds belonging to families of interest such as flavonoids, sesquiterpenoids, and coumarins, hoping to arouse the interest of other researchers to further investigate the activities, properties and uses attributed to Flourensia cernua.